$1.51
+0.03
(+2.38%)▲
2.03%
Downside
Day's Volatility :5.17%
Upside
3.21%
51.5%
Downside
52 Weeks Volatility :87.33%
Upside
73.88%
Period | Assertio Holdings, Inc. | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 77.49% | 6.5% | 0.0% |
6 Months | 67.48% | 7.1% | 0.0% |
1 Year | -73.22% | 9.8% | 0.0% |
3 Years | 22.5% | 14.2% | -20.2% |
Market Capitalization | 154.1M |
Book Value | $1.41 |
Earnings Per Share (EPS) | -4.65 |
PEG Ratio | 1.2 |
Wall Street Target Price | 3.19 |
Profit Margin | -234.4% |
Operating Margin TTM | -11.15% |
Return On Assets TTM | 1.35% |
Return On Equity TTM | -172.9% |
Revenue TTM | 142.1M |
Revenue Per Share TTM | 1.73 |
Quarterly Revenue Growth YOY | -23.599999999999998% |
Gross Profit TTM | 138.3M |
EBITDA | 35.0M |
Diluted Eps TTM | -4.65 |
Quarterly Earnings Growth YOY | -0.19 |
EPS Estimate Current Year | -0.15 |
EPS Estimate Next Year | -0.02 |
EPS Estimate Current Quarter | -0.03 |
EPS Estimate Next Quarter | -0.02 |
What analysts predicted
Upside of 111.26%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 311.8M | ↓ 18.11% |
Net Income | 36.9M | ↓ 136.01% |
Net Profit Margin | 11.84% | ↑ 38.76% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 229.5M | ↓ 26.39% |
Net Income | -217.2M | ↓ 688.49% |
Net Profit Margin | -94.64% | ↓ 106.48% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 106.3M | ↓ 53.69% |
Net Income | -28.1M | ↓ 87.04% |
Net Profit Margin | -26.48% | ↑ 68.16% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 111.0M | ↑ 4.46% |
Net Income | -1.3M | ↓ 95.45% |
Net Profit Margin | -1.15% | ↑ 25.33% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 156.2M | ↑ 40.73% |
Net Income | 109.6M | ↓ 8657.77% |
Net Profit Margin | 70.17% | ↑ 71.32% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 152.1M | ↓ 2.67% |
Net Income | -331.9M | ↓ 402.8% |
Net Profit Margin | -218.28% | ↓ 288.45% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 50.4M | ↑ 47.18% |
Net Income | 88.6M | ↑ 2021.54% |
Net Profit Margin | 175.86% | ↑ 163.66% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 42.5M | ↓ 15.66% |
Net Income | -3.5M | ↓ 103.93% |
Net Profit Margin | -8.2% | ↓ 184.06% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 41.0M | ↓ 3.47% |
Net Income | 8.5M | ↓ 343.11% |
Net Profit Margin | 20.66% | ↑ 28.86% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 35.6M | ↓ 13.09% |
Net Income | -279.5M | ↓ 3400.4% |
Net Profit Margin | -784.64% | ↓ 805.3% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 33.0M | ↓ 7.42% |
Net Income | -57.4M | ↓ 79.47% |
Net Profit Margin | -173.97% | ↑ 610.67% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 32.4M | ↓ 1.63% |
Net Income | -4.5M | ↓ 92.14% |
Net Profit Margin | -13.9% | ↑ 160.07% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 932.9M | ↓ 10.18% |
Total Liabilities | 712.5M | ↓ 18.02% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 527.2M | ↓ 43.49% |
Total Liabilities | 469.2M | ↓ 34.15% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 303.3M | ↓ 42.47% |
Total Liabilities | 247.8M | ↓ 47.2% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 326.5M | ↑ 7.67% |
Total Liabilities | 224.1M | ↓ 9.54% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 413.9M | ↑ 26.75% |
Total Liabilities | 188.2M | ↓ 16.04% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 286.4M | ↓ 30.8% |
Total Liabilities | 148.4M | ↓ 21.13% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 413.9M | ↑ 28.01% |
Total Liabilities | 188.2M | ↓ 0.13% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 414.3M | ↑ 0.09% |
Total Liabilities | 163.6M | ↓ 13.06% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 405.2M | ↓ 2.2% |
Total Liabilities | 150.9M | ↓ 7.76% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 380.0M | ↓ 6.21% |
Total Liabilities | 187.2M | ↑ 24.02% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 286.4M | ↓ 24.63% |
Total Liabilities | 148.4M | ↓ 20.7% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 282.0M | ↓ 1.56% |
Total Liabilities | 147.5M | ↓ 0.64% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 72.5M | ↑ 16.62% |
Investing Cash Flow | -7.1M | ↓ 112.23% |
Financing Cash Flow | -81.4M | ↓ 26.64% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 90.5M | ↑ 24.8% |
Investing Cash Flow | -1.5M | ↓ 79.09% |
Financing Cash Flow | -157.8M | ↑ 94.02% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -65.6M | ↓ 172.48% |
Investing Cash Flow | 512.8M | ↓ 34725.32% |
Financing Cash Flow | -468.6M | ↑ 196.86% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 5.5M | ↓ 108.42% |
Investing Cash Flow | -18.5M | ↓ 103.61% |
Financing Cash Flow | 29.0M | ↓ 106.19% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 78.6M | ↑ 1323.1% |
Investing Cash Flow | -42.7M | ↑ 130.35% |
Financing Cash Flow | -7.8M | ↓ 126.85% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 26.7M | ↑ 165.77% |
Investing Cash Flow | -25.8M | ↑ 6849.87% |
Financing Cash Flow | -798.0K | ↓ 127.63% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 22.7M | ↓ 14.91% |
Investing Cash Flow | -703.0K | ↓ 97.27% |
Financing Cash Flow | -19.0M | ↑ 2274.69% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 18.6M | ↓ 18.12% |
Investing Cash Flow | -703.0K | ↑ 0.0% |
Financing Cash Flow | -16.3M | ↓ 13.85% |
Sell
Neutral
Buy
Assertio Holdings, Inc. is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Assertio Holdings, Inc. | 21.49% | 67.48% | -73.22% | 22.5% | -88.3% |
![]() Neurocrine Biosciences Inc. | 7.56% | 2.78% | 45.55% | 52.55% | 67.01% |
![]() Haleon Plc Spon Ads | 7.53% | 11.87% | 3.28% | 23.35% | 23.35% |
![]() Zoetis Inc. | 5.77% | -5.62% | -5.85% | -9.99% | 57.03% |
![]() Viatris Inc. | 12.75% | -1.42% | 12.21% | -15.03% | -28.03% |
![]() Catalent, Inc. | 4.08% | 11.91% | 19.53% | -48.27% | 2.08% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Assertio Holdings, Inc. | 1.2 | NA | 1.2 | -0.15 | -1.73 | 0.01 | NA | 1.41 |
![]() Neurocrine Biosciences Inc. | 39.75 | 39.75 | 0.44 | 3.99 | 0.18 | 0.1 | NA | 23.72 |
![]() Haleon Plc Spon Ads | 29.9 | 29.9 | 1.69 | 0.39 | 0.07 | 0.04 | 0.02 | 1.8 |
![]() Zoetis Inc. | 34.62 | 34.62 | 2.58 | 5.77 | 0.5 | 0.14 | 0.01 | 11.07 |
![]() Viatris Inc. | 224.4 | NA | 0.06 | 2.73 | 0.0 | 0.03 | 0.04 | 16.81 |
![]() Catalent, Inc. | 211.02 | NA | 2.06 | 0.2 | -0.28 | -0.01 | NA | 19.96 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Assertio Holdings, Inc. | Buy | $154.1M | -88.3% | 1.2 | -234.4% |
![]() Neurocrine Biosciences Inc. | Buy | $14.7B | 67.01% | 39.75 | 18.65% |
![]() Haleon Plc Spon Ads | Buy | $41.0B | 23.35% | 29.9 | 9.64% |
![]() Zoetis Inc. | Buy | $82.0B | 57.03% | 34.62 | 27.38% |
![]() Viatris Inc. | Hold | $14.2B | -28.03% | 224.4 | -0.37% |
![]() Catalent, Inc. | Hold | $10.6B | 2.08% | 211.02 | -28.44% |
Insights on Assertio Holdings, Inc.
Revenue is down for the last 6 quarters, 50.35M → 32.44M (in $), with an average decrease of 8.3% per quarter
Netprofit is up for the last 3 quarters, -279.54M → -4.51M (in $), with an average increase of 779.8% per quarter
In the last 1 year, Neurocrine Biosciences Inc. has given 45.5% return, outperforming this stock by 118.7%
In the last 3 years, Neurocrine Biosciences Inc. has given 52.6% return, outperforming this stock by 30.1%
Nantahala Capital Management, LLC
BlackRock Inc
Vanguard Group Inc
AQR Capital Management LLC
Renaissance Technologies Corp
Geode Capital Management, LLC
assertio reflects an aspirational mindset that is forward thinking, energetic, and entrepreneurial in spirit. ticker symbol: asrt
Organization | Assertio Holdings, Inc. |
Employees | 53 |
CEO | Ms. Heather L. Mason |
Industry | Health Technology |
A Spac I Acquisition Corp
$1.51
+2.38%
Keyarch Acquisition Corp
$1.51
+2.38%
Connexa Sports Technologies Inc
$1.51
+2.38%
Us Value Etf
$1.51
+2.38%
First Wave Biopharma Inc
$1.51
+2.38%
Global X Msci Next Emerging
$1.51
+2.38%
Fat Projects Acquisition Corp
$1.51
+2.38%
Capital Link Global Fintech
$1.51
+2.38%
Applied Uv Inc
$1.51
+2.38%